Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells (Q33875995)

29 July 2017

title

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells (English)

1 reference

medroxyprogesterone acetate

29 July 2017

main subject

1 reference

1 reference

Bentel JM

1

1 reference

29 July 2017

Birrell SN

2

1 reference

29 July 2017

Pickering MA

3

1 reference

29 July 2017

Holds DJ

4

1 reference

29 July 2017

Horsfall DJ

5

1 reference

29 July 2017

Tilley WD

6

1 reference

29 July 2017

publication date

1 August 1999

1 reference

Molecular and Cellular Endocrinology

29 July 2017

published in

1 reference

29 July 2017

volume

154

1 reference

29 July 2017

issue

1-2

1 reference

29 July 2017

page(s)

11-20

1 reference

Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH)

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Androgens induce divergent proliferative responses in human breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Role of the androgen receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Functional activities of the A and B forms of the human androgen receptor in response to androgen receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

The Effect of Medroxyprogesterone Acetate on the Pituitary-Adrenal Axis

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

The binding of progesterone, R-5020 and ORG-2058 to progesterone receptor

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Development and characterization of primary cultures of smooth muscle cells from the fibromuscular stroma of the guinea pig prostate

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Endocrine treatment of breast cancer in women

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Characterization and expression of a cDNA encoding the human androgen receptor

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

A structural role for hormone in the thyroid hormone receptor.

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Atomic structure of progesterone complexed with its receptor

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

A canonical structure for the ligand-binding domain of nuclear receptors

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.

1 reference

https://api.crossref.org/works/10.1016/S0303-7207(99)00109-4

7 January 2021

10.1016/S0303-7207(99)00109-4

Identifiers

DOI

1 reference

29 July 2017

1 reference